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Abstract
In statistical genetics, genetic association and genomic prediction become more successful with a
highly heritable trait. Identifying highly heritable components of a complex disease can thus
advance scientific understanding of the disease and potentially lead to effective prevention and
treatments. Using Matlab and existing large-scale genome datasets, we evaluate a restricted
maximum likelihood approach to identify highly heritable components of a complex disease as a
function of multiple clinical variables.
Keywords: chip heritability, genome-wide association study, restricted maximum likelihood,
mixed-effect linear model, quadratic programming
1. Introduction

Statistical genetics is a scientific field focused on developing mathematical models and statistical
inference methodologies to draw inferences from genetic data [1, 2]. Statistical methods are
often used for genetic association and genomic prediction. Genetic association is commonly
defined as the relationship between a phenotype and a genetic polymorphism (such as single
nucleotide polymorphism) or between two genetic polymorphisms [3]. Genomic prediction is to
predict a future genetic value or phenotypic trait of an individual. The ability to translate
genotype information into the prediction of disease phenotypes is important for precision
medicine [4].
The success of both genetic association and genomic prediction are positively associated with the
heritability of the trait used in the analysis. Identifying highly heritable components of a complex
disease can thus advance scientific understanding of the disease and potentially lead to effective
prevention and treatments.
Existing heritable component analysis methods use data from related individuals to compute
linearly-combined traits to maximize heritability. However, very limited data sets from related
individuals are available. Furthermore, data sets from twins and families often involve built-in
biases. With privacy and other data collection constraints, most available genotypic data are from
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apparently unrelated individuals. Recent advances in acquiring genome-wide markers have
enhanced heritability estimation using genotypic data from apparently unrelated individuals.
A genome-wide association study (GWAS) is a research approach used to identify genomic
variants that are statistically associated with a risk for a disease or a particular trait. The method
involves surveying the genomes of many people, looking for genomic variants that occur more
frequently in those with a specific disease or trait compared to those without the disease or trait.
Once such genomic variants are identified, they are typically used to search for nearby variants
that contribute directly to the disease or trait [5].
Genome-wide genetic data has also provided new opportunities to estimate genetic relatedness
using mixed-model analysis. The principle behind mixed-model analyses is the same as twin and
family-based heritability analyses — heritability is estimated via correlation between genetic
sharing and phenotypic sharing. The key difference is that rather than using the theoretical
estimates of genetic sharing based on Mendel’s laws, in mixed-model analysis, empirical
estimates of genetic sharing are used and are directly observed from genotype data. Estimates of
genetic sharing, often represented as a genetic relationship matrix, can then be used in a variety
of statistical analyses. These analyses are typically based on data from large scale genome-wide
single nucleotide polymorphism (SNP) genotyping arrays [6].
Genetic relationship matrices use genotyped SNPs from GWAS datasets to estimate genomic
sharing among individuals in a study sample. Using these estimates of genomic sharing,
investigators can statistically model the proportion of trait variance explained by this sharing. If
the information captured by the GWAS dataset represented 100% of all genetic variation, this
analysis would have yielded a perfectly accurate estimate of trait heritability. Because
genotyping technologies do not capture all genetic variation, the estimates of genomic sharing
are limited to genetic variants directly genotyped (or variants in strong linkage disequilibrium).
Therefore, when properly adjusted for confounding factors, the variance explained by genetic
sharing of GWAS-genotyped SNPs — often referred to as chip heritability or pseudo-heritability
— can be considered a surrogate for narrow-sense heritability (or heritability due to additive
genetic effects).
Novel statistical models are thus needed to identify disease components (subtypes) with high
chip heritability from very large scale data. The research problem in this project is to evaluate a
novel statistical model based on Restricted Maximum Likelihood (REML). Compared to the
common maximum likelihood estimate (MLE) methods in statistics, REML estimation is often
used in the more complicated context of mixed models with fixed effects from covariates.
2. Optimization Problem

Given a set of n subjects, we denote their trait values of a quantitative trait y by a vector y of
length n. We use a matrix Zn×m to represent their standardized genotypic data at m genetic
markers, and Cn×p to represent their data on p covariates. The chip heritability estimation
method [7] assumes the following mixed-effect linear model that characterizes how a phenotype
is related to genotypes and covariates:
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y=Cβ+Zu+ε

(1)

where ε is a vector of length n, which specifies residual effects. In Eq.(1), all covariates create
fixed effects (fixed β) on the phenotype whereas genetic effects are random (random u). Assume
that u and ε are independent and follow Gaussian distributions: u ~ N (0, σe2) and ε ~ N (0, Iσu2).
Then, the covariance of y between individuals, denoted by Ω n×n , can be calculated as:
Ω=ZZTσu2+Iσe2

(2)

A definitive quantitative trait y is not known beforehand but needs to be derived from a set of
known clinical variables. Let X n×d be the data matrix of d clinical variables x for the same n
subjects as in Z. A trait y is defined by a linear function of y = w┬x where w is the vector of
combination coefficients. Correspondingly, the trait values y = Xw.
The problem now is to search for the best w to form a trait y that maximizes the likelihood, i.e., a
large σu2 but small σe2.
3. Methodology

Using Matlab and existing large-scale genome datasets, we evaluate an REML-based quadratic
programming approach to identification of highly heritable components of a complex disease as
a function of multiple clinical variables [7]. The heritability of the components is estimated
directly from unrelated individuals using their genome-wide single nucleotide polymorphisms
(SNPs). This REML-based approach is designed to accommodate fixed effects due to covariates,
such as age and race, so that the derived traits have high chip heritability after correcting for
fixed effects.
In this REML-based approach, a sequential quadratic programming algorithm is used to
efficiently solve the optimization problem. This project validates the algorithm both in
simulations and on a real-world dataset that was aggregated from genetic studies of cocaine,
opioid, and alcohol dependence [7].
4. Implementation of Quadratic Programming Algorithm

The algorithm proposed by Sun et al [7] is a sequential quadratic programming approach to
solving the optimization problem.
We decompose w into two parts: w = u − v, where both u and v are vectors of the same size as
that of w, and all the components in u and v are required to be non-negative (i.e., u ≥ 0, and v ≥
0). Because Xw=Xu−Xv, we denote γ= [uT , vT ]T , H = [X , − X], and then we have Xw = H γ.
By the change of variables, and using the L1 vector norm of w as a regularizing factor to prevent
overfitting [8], the optimization problem can be equivalently rewritten as:
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where f denotes the objective function, H = [X , − X], X n×d is the data matrix of d clinical
variables x for the same n subjects, g's denote the constraints, and e = 2d + 1, indicating the
number of constraints in that group, and P and Q defined as follows:
P = G-1 – G-1C(CTG-1C)-1CTG-1

(3)

where G = ZZT/m, which is also the genetic relationship matrix (GRM) among subjects
determined by the causal variants.
Q = 1/n * JTJ

(4)

where J is calculated by J = I – C(CTΩ-1C)-1CTΩ-1 and Ω is the covariance matrix in Eq.(2).
Below is the quadratic programming algorithm [7]:
Input: Z, C, X, λ
Output: γ 1.
The steps followed:
1.
2.
3.
4.
5.
6.
7.

Calculate P according to Eq.(3), and Q according to Eq.(4).
Initialize with u=1, v=0.
Initialize the Lagrange multipliers α =1.
Evaluate f,▽f, ▽gi and ▽2L with the current γ and α.
Obtain
as detailed below.
Perform a line search to find the searching step size s.
Update γ and α as in Eq.(5). Repeat 4-7 until γ reaches a fixed point.

The above update to γ follows the direction along which the minimization objective of the
optimization problem can be decreased the most.
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5. Results and Conclusion

Using Matlab to implement the algorithm, simulation studies demonstrate that the evaluated
approach can identify the hypothesized component from multiple synthesized features. A case
study on cocaine dependence using an existing dataset [7] confirms a quantitative trait that
achieved high chip heritability, where the quantitative trait corresponds to the likelihood of an
individual’s membership in a cocaine dependence subtype.
Limitations of Study
One underlying assumption, as in other chip heritability studies, is that the genetic variants
captured by the genome-wide SNPs tag rare and structural variation with enough accuracy to
properly estimate their effects along with those of common SNPs.
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